BILLS-119hr6214ih.pdf - Research Document Archive

Loading OCR text...

DATE (21)

2025 21:09 Dec 01 6214 IH 42 January 1, 2026 6214 January 1 2026 January 1, 2020 January 1, 2024 years 18:26 Dec 06 12- 11 month 2022 1ST SESSION H. R. 6214 NOVEMBER 20, 2025 the previous year annual 2021 less than 3 years 3 years

FAC (12)

PO 00000 Frm PO 00000 Frm 00010 PO 00000 Frm 00005 PO 00000 Frm 00006 PO 00000 Frm 00012 PO 00000 Frm 00007 PO 00000 Frm 00009 PO 00000 Frm 00003 Fmt PO 00000 Frm 00015 PO 00000 Frm 00001 PO 00000 Frm 00004 PO 00000 Frm 00011 Fmt

GPE (2)

West Virginia the United States of America

ORG (19)

SEC MEDICARE ESRD the Federal Food, Drug Senate Congress Health and Human Services Food and Drug Administration U.S.C. House of Representa- 1851(i THE HOUSE OF REPRESENTATIVES the Committee on Ways and Means the Food and Drug Adminis- the Committee on Energy and Commerce

PERSON (3)

SEWELL BIOLOGICALS MILLER

Topic Classifications

congressional legislation 92.9%

public health 42.2%

government oversight 22.0%

Extracted Keywords

add adjustment biological product drug transitional stage improve access disease drug product innovative biological product options medicare calendar quarter

Forensic Analysis

PDF Metadata

Creator: U.S. Gov. Printing Office -- G.S.D.D.
ModDate: D:20251209095427Z
Producer: Acrobat Distiller 25.0 (Windows); modified using iText® Core 9.2.0 (production version) ©2000-2025 Apryse Group NV, Government Publishing Office
CreationDate: D:20251208195452-05'00'

Sentiment

Polarity

Neutral

0.046

Subjectivity

47%

Objective

No crisis correlations found for this document.

The ML pipeline may still be processing.